AI-Enhanced Electronic Health Records (EHRs) Market Size, Share, Growth Trends, Forecast 2026-2033

AI-Enhanced Electronic Health Records (EHRs) Market is segmented By EHR Type, By Technology, By Application, By End User and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Last Updated: || Author: Rohan Sawant || Reviewed: Akshay Reddy || SKU: HCIT8598

Report Summary
Table of Contents

Market Size 2035

US$ 84.95 Bn

CAGR (2026-2035)

26.2%

Dominating Segment

On-Premise EHR Software

Leading Region

North America

AI-Enhanced Electronic Health Records Market Size & Growth

Healthcare providers are under pressure to turn patient records into usable clinical intelligence while reducing documentation burden, improving diagnosis, and controlling operating costs. AI-enhanced electronic health records are becoming strategically important because they combine core EHR infrastructure with predictive analytics, machine learning, deep learning, workflow automation, clinical decision support and patient-generated health data analysis.

AI-Enhanced Electronic Health Records Market is valued at US$ 8.29 billion in 2025 and is projected to reach US$ 84.95 billion by 2035, growing at a CAGR of 26.2% during 2026–2035.

The investment timing is significant because healthcare organizations already have a strong digital foundation. Over 95% of hospitals in the U.S. have adopted EHR systems, creating a large base of structured and unstructured data that can be enhanced through AI. The commercial case is no longer limited to record digitization. Buyers are now evaluating AI-enabled EHR platforms for early disease detection, hospitalization prediction, radiology insight extraction, personalized treatment planning, workflow automation and patient outcome improvement.

AI-enabled Electronic Health Records (EHR) market 2025
Source: DataM Intelligence

AI-Enhanced Electronic Health Records Market: Key Takeaways

  • The AI-Enhanced Electronic Health Records Market 2026 value is recalculated at US$10.46 billion, reflecting accelerating adoption of AI-based clinical intelligence across digital health systems.
  • The AI-Enhanced Electronic Health Records Market 2035 value is projected at US$84.95 billion, supported by a 26.2% CAGR from 2026 to 2035.
  • North America is expected to hold 41.8% of the global AI-Enhanced Electronic Health Records Market Share. Applied to the 2025 market size, this equals approximately US$3.47 billion.
  • On-premise EHR software is expected to hold 42.7% market share. Applied to 2025 value, this represents approximately US$3.54 billion.
  • The strongest buyer rationale is linked to predictive analytics, early disease detection, hospital admission risk prediction, clinical workflow automation and personalized care delivery.
  • Data privacy and patient data security remain major restraints because AI-enabled EHRs process large volumes of sensitive clinical and personal health information.
  • Companies such as eClinicalWorks, ScienceSoft USA Corporation, Oracle, Medical Information Technology, Inc., athenahealth and Eleos Health are competing in a market where differentiation depends on AI integration depth, clinical usability, compliance readiness and workflow fit.

AI-Enhanced Electronic Health Records Market Scope

Report AttributeDetails
Market Size in 2025US$8.29 billion
Market Size by 2035US$84.95 billion
CAGR26.2% during 2026 to 2035
Historic Years2023 to 2024
Base Year2025
Forecast Period2026 to 2035
Segments CoveredEHR Type, Technology, Application, End User and Region
Leading RegionNorth America

Clinical Intelligence Is Becoming the Next Layer of EHR Investment

Advanced Data Analytics Is Driving Market Growth

The increasing adoption of advanced data analytics is a central driver of AI-Enhanced Electronic Health Records Market Growth. Healthcare providers are using AI-enhanced systems to extract insights from large volumes of patient data, including medical history, patient-generated health data, diagnostic records, clinician notes and imaging-related information.

Predictive and prescriptive analytics allow clinicians to identify health risks earlier, anticipate hospitalization probability, optimize treatment plans and improve care coordination. For hospitals and health systems, the business value is tied to better clinical outcomes, more efficient workflows and lower avoidable costs. This makes AI-enhanced EHR adoption a strategic technology investment rather than a back-office IT upgrade.

Patient-Generated Health Data Expands the EHR Use Case

Patient-generated health data is becoming more relevant as care delivery shifts beyond hospital walls. Wearables, remote monitoring tools, telehealth platforms and digital patient engagement systems are creating new data streams. AI-enabled EHR platforms help interpret this information and convert it into clinical signals.

For care teams, this improves the ability to monitor chronic conditions, personalize treatment and detect risk patterns before escalation. For executives, the value lies in supporting proactive care models, improving patient satisfaction and enabling more data-driven population health management.

AI-Assisted Diagnosis and Imaging Insights Improve Clinical Utility

AI-enhanced EHR systems can support earlier detection of medical conditions by connecting patient history, clinical data and diagnostic inputs. The source content highlights AI’s ability to help physicians identify health concerns, predict hospitalizations and detect disease early. AI can also extract insights from X-rays, scans and other radiology images, improving the practical value of EHR-connected clinical workflows.

This positions AI-enhanced EHR platforms as decision-support assets. They do not replace physicians, but they can help reduce missed signals, speed up review, prioritize cases and support more consistent patient evaluation.

Data Privacy and Security Shape Procurement Decisions

The main restraint in the AI-Enhanced Electronic Health Records Market Analysis is concern over data privacy and safety. AI integration requires the handling of large volumes of sensitive patient data. Healthcare organizations face reputational, financial and legal risks if data breaches occur, and patients are becoming more cautious about how their health data is used.

This means procurement cycles are likely to remain highly compliance-driven. Vendors must prove strong encryption, access controls, auditability, governance, data protection and regulatory alignment. Buyers are also expected to assess whether AI models can be deployed in ways that preserve patient confidentiality while still delivering meaningful clinical and operational benefits.

AI-Enhanced Electronic Health Records Market Opportunities

AI-enhanced EHR platforms create opportunities for healthcare providers, technology vendors, investors and virtual care companies. For hospitals, the opportunity is to improve clinician productivity, strengthen diagnosis, personalize treatment planning and reduce administrative friction. For EHR vendors, AI integration creates a pathway to defend market share, raise product value and build recurring software revenue.

Technology companies can benefit by offering AI modules for predictive analytics, automated documentation, patient risk scoring, clinical decision support and workflow optimization. Virtual care providers can use AI-enabled EHR infrastructure to build more intelligent telehealth platforms that support triage, patient history summarization and care continuity.

Investors should track companies that combine healthcare workflow knowledge with AI capability. The most valuable opportunities are likely to sit at the intersection of EHR integration, patient data analytics, clinical usability and compliance-led deployment.

Economic and Investment Analysis

Macroeconomic pressure on healthcare systems is increasing interest in technologies that improve productivity and reduce avoidable costs. AI-enhanced EHR systems address several cost-sensitive areas, including clinician documentation time, diagnostic inefficiency, repeated manual workflows and fragmented care coordination.

Capital expenditure is likely to be directed toward EHR modernization, AI modules, analytics engines, security infrastructure and integration services. On-premise deployment remains attractive for organizations requiring direct data control, but cloud-connected and hybrid architectures may gain relevance where scalability and faster implementation are priorities.

The ROI case depends on measurable improvements in clinical workflow efficiency, earlier risk detection, reduced administrative burden, better patient outcomes and lower operational cost. Key economic risks include privacy breaches, integration complexity, clinician resistance, model governance costs and uncertain returns from poorly implemented AI tools.

AI-Enhanced Electronic Health Records Market Segmentation Analysis

The AI-Enhanced Electronic Health Records Market Report is segmented by EHR Type, by Technology, by Application, by End User, and by Region - Share, Trends, and Forecast to 2035.

On-Premise EHR Software Leads by Deployment Preference

The on-premise EHR software segment is expected to hold 42.7% of the global market. Based on the 2025 market size, this equals approximately US$3.54 billion. The segment leads because many healthcare organizations prefer direct control over patient data, security configurations and compliance procedures.

On-premise systems also support integration with existing legacy infrastructure. This is important for hospitals and large healthcare networks that want to add AI functionality without replacing core EHR systems. The ability to customize security, workflows and AI integration makes on-premise EHR software attractive in regions with strict data protection requirements.

Predictive Analytics and Machine Learning Support Clinical Decision-Making

By technology, AI-enhanced EHR platforms rely on predictive analytics, machine learning, deep learning and advanced data analysis. Predictive analytics is especially valuable because it supports early risk identification, hospitalization prediction and care pathway optimization.

Machine learning and deep learning strengthen EHR intelligence by identifying patterns across structured and unstructured patient data. These technologies help improve diagnosis, support personalized treatment planning and assist clinicians with prioritizing patient needs.

Applications Are Expanding from Records Management to Care Optimization

AI-enhanced EHR applications include clinical decision support, patient data analysis, workflow automation, personalized treatment planning, diagnostic support and patient engagement. Clinical decision support is commercially important because it connects directly to physician productivity and care quality.

Workflow automation is also gaining buyer attention. Hospitals and clinics need tools that reduce repetitive administrative tasks, improve documentation, and help clinicians spend more time on patient care. Personalized treatment planning offers longer-term growth potential as healthcare organizations increase focus on proactive and patient-specific care.

End Users Prioritize Efficiency, Compliance and Better Outcomes

Hospitals, clinics, health systems, virtual care providers and healthcare technology organizations are key end users. Large hospitals are more likely to adopt early because they have stronger IT infrastructure, higher patient volumes and greater demand for advanced analytics.

Smaller providers may adopt more selectively due to cost, integration and security concerns. However, as AI-enabled EHR products become more modular and easier to deploy, adoption may broaden across ambulatory care and digital health settings.

AI-Enhanced Electronic Health Records Market Regional Analysis

North America Leads the Market

North America is expected to hold 41.8% of the global AI-Enhanced Electronic Health Records Market Share. Applied to the 2025 market value, this equals approximately US$3.47 billion. The region benefits from high EHR adoption, advanced healthcare IT infrastructure, strong AI vendor presence and rising demand for cost-efficient clinical decision-making.

The United States is the most important country market in the region because over 95% of hospitals have adopted EHR systems. This creates a large digital data foundation for AI-enhanced capabilities. Demand is supported by healthcare organizations seeking predictive modeling, personalized treatment planning, workflow automation and better patient outcomes.

Canada also presents opportunities due to digital health adoption and demand for healthcare efficiency, although country-specific market size is not disclosed in the source content. The main regional barriers include privacy concerns, cybersecurity risk, interoperability challenges and the need for clear ROI evidence.

Europe Focuses on Privacy, Interoperability and Clinical Governance

Europe’s AI-enhanced EHR adoption is likely to be shaped by strict data protection expectations and the need for trusted clinical AI. Healthcare systems in the region are expected to prioritize privacy, patient consent, secure data handling and interoperability before scaling AI-enabled EHR deployments.

Demand will be stronger where hospitals and public health systems are investing in digital records, population health analytics and integrated care delivery. Vendors entering Europe must align product strategy with compliance, auditability and clinical governance rather than relying only on AI performance claims.

Asia-Pacific Offers Long-Term Digital Health Potential

Asia-Pacific is expected to offer long-term market potential as healthcare systems digitize records, invest in hospital modernization and expand AI-enabled care infrastructure. Country-level market values are not provided in the source content, but the region’s opportunity is linked to increasing healthcare digitization, growing patient volumes and demand for more efficient clinical workflows.

India, China, Japan, South Korea and Australia are relevant markets for AI-enhanced EHR adoption, although adoption speed will vary based on data infrastructure, healthcare IT budgets, regulatory maturity and interoperability readiness. Cost sensitivity and fragmented systems may slow adoption in some markets, but the long-term need for scalable digital healthcare tools remains significant.

Country-Level Market Analysis

The United States is the clearest country-level demand center because EHR adoption exceeds 95% among hospitals, creating a strong base for AI integration. Growth drivers include predictive analytics adoption, administrative automation, hospital cost pressure and demand for improved patient outcomes. Key challenges include data privacy, cybersecurity and integration with legacy systems.

Canada is positioned for adoption through healthcare digitization and interest in patient outcome improvement, although country-level market size and growth rate are not disclosed. Europe’s leading healthcare markets are expected to focus on compliant AI deployment, while Asia-Pacific countries may generate future opportunities through expanding digital health infrastructure and rising healthcare IT investments.

Country-specific market values are not available in the source content, so no country revenue figures are added.

Regulatory and Policy Analysis

AI-enhanced EHR platforms operate in a highly regulated healthcare environment because they process sensitive patient data. Regulations related to patient privacy, data protection, cybersecurity, medical records management and healthcare technology procurement influence adoption.

The main business impact is that vendors must demonstrate secure data handling, strong access controls, compliance readiness and reliable governance. Healthcare providers will need clear policies around AI use, patient data protection, model accountability and clinician oversight.

Expected regulatory scrutiny may increase as AI becomes more embedded in clinical workflows. This is likely to favor vendors that can provide transparent, secure and clinically validated solutions.

Competitive Landscape and Vendor Positioning

The AI-Enhanced Electronic Health Records Market includes companies such as eClinicalWorks, ScienceSoft USA Corporation, Oracle, Medical Information Technology, Inc., athenahealth and Eleos Health. These companies compete across EHR platforms, healthcare software services, AI-enabled clinical workflows, data analytics and documentation support.

Oracle and Medical Information Technology, Inc. are positioned through healthcare IT and EHR infrastructure. eClinicalWorks and athenahealth are relevant because of their EHR and ambulatory care software presence. Eleos Health is positioned around AI-supported clinical documentation and behavioral health workflow use cases. ScienceSoft USA Corporation participates through healthcare software development and AI integration services.

Competitive differentiation will depend on how well vendors integrate AI into real clinical workflows. Buyers are likely to evaluate accuracy, usability, interoperability, data security, implementation support and measurable productivity gains. Strategic partnerships between healthcare software companies and AI infrastructure providers will remain important as hospitals seek advanced AI capabilities within trusted EHR environments.

Recent Developments in AI-Enhanced Electronic Health Records Market

  • June 2026 – Oracle expands AI-powered Electronic Health Record capabilities
    Oracle enhanced its Oracle Health EHR platform by introducing advanced generative AI, intelligent clinical documentation, AI-assisted chart summarization, and workflow automation to reduce clinician administrative burden and improve care delivery.
  • June 2026 – athenahealth advances AI-enabled clinical documentation
    athenahealth expanded its AI-powered EHR platform with enhanced ambient clinical documentation, AI-generated patient summaries, and intelligent workflow automation, helping healthcare providers improve productivity and patient engagement.
  • May 2026 – eClinicalWorks strengthens AI-driven EHR workflows
    eClinicalWorks enhanced its cloud-based EHR platform by expanding Sunoh AI-powered medical scribing, automated clinical documentation, and AI-assisted patient engagement tools, enabling physicians to reduce documentation time and improve workflow efficiency.
  • April 2026 – MEDITECH advances Expanse AI capabilities
    Medical Information Technology, Inc. (MEDITECH) expanded its Expanse EHR platform with enhanced generative AI features, intelligent search, ambient documentation, and clinical decision support to streamline healthcare operations and improve clinician efficiency.
  • March 2026 – Eleos Health enhances AI-powered behavioral health documentation
    Eleos Health expanded its AI platform with improved automated clinical note generation, session insights, compliance documentation, and quality assurance tools for behavioral health providers, reducing administrative workload and supporting value-based care.
  • February 2026 – Oracle strengthens AI-assisted healthcare interoperability
    Oracle expanded AI capabilities across Oracle Health by enhancing interoperability, clinical data intelligence, and automated care coordination, enabling more efficient health information exchange and personalized patient care.

Strategic Insights and Analyst Perspective

AI-enhanced EHR adoption is becoming a strategic decision for healthcare executives because it affects clinical quality, operational cost, patient engagement and data governance. The market’s growth outlook is strong, but vendors must avoid positioning AI as a generic add-on. Healthcare buyers need tools that solve specific problems, such as documentation burden, diagnostic support, patient risk prediction and workflow inefficiency.

For investors, the most attractive companies are likely to be those with EHR workflow depth, healthcare compliance capability and AI models that can be embedded into daily clinical practice. For healthcare providers, vendor selection should focus on data security, implementation burden, clinician adoption, interoperability and measurable ROI.

The market will reward platforms that combine AI capability with healthcare-specific trust. In this category, clinical reliability and compliance will matter as much as model performance.

Report Benefits

This AI-Enhanced Electronic Health Records Market Report helps healthcare technology vendors assess product direction, market demand and competitive positioning. Investors can evaluate growth opportunities linked to predictive analytics, workflow automation and AI-enabled clinical intelligence. Healthcare providers can use the report to benchmark adoption drivers, barriers and ROI considerations. Procurement teams can compare deployment models, vendor positioning and implementation risks. Strategy teams can identify regional opportunities, target end users and long-term technology trends.

Target Audience

  • Electronic Health Record (EHR) vendors
  • Healthcare AI companies
  • Hospitals and healthcare systems
  • Clinics and ambulatory care providers
  • Virtual care and telehealth providers
  • Integrated health systems
  • Healthcare IT service providers
  • Cloud and infrastructure companies
  • Investors in healthcare IT and digital health sector
  • Private equity firms
  • Venture capital firms
  • Procurement heads
  • Chief Information Officers (CIOs)
  • Chief Technology Officers (CTOs)
  • Chief Financial Officers (CFOs)
  • Clinical operations leaders
  • Product managers
  • Regulatory affairs teams
  • Corporate strategy teams

Why purchase AI-Enhanced Electronic Health Records (EHRs) Market report?

Technological Innovations

Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.

Product Performance & Market Positioning

Analyzes product performance, market positioning, and growth potential to optimize strategies.

Real-World Evidence

Integrates patient feedback and data into product development for improved outcomes.

Physician Preferences & Health System Impact

Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.

Market Updates & Industry Changes

Covers recent regulatory changes, new policies, and emerging technologies.

Competitive Strategies

Analyzes competitor strategies, market share, and emerging players.

Pricing & Market Access

Reviews pricing models, reimbursement trends, and market access strategies.

Market Entry & Expansion

Identifies optimal strategies for entering new markets and partnerships.

Regional Growth & Investment

Highlights high-growth regions and investment opportunities.

Supply Chain Optimization

Assesses supply chain risks and distribution strategies for efficient product delivery.

Sustainability & Regulatory Impact

Focuses on eco-friendly practices and evolving regulations in healthcare.

Post-market Surveillance

Uses post-market data to enhance product safety and access.

Pharmacoeconomics & Value-Based Pricing

Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

Target Audience 2026

Manufacturers

Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.

Regulatory & Policy

Compliance Officers, Government, Health Economists, Market Access Specialists.

Application & Innovation

AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.

Investors

Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.

Consulting & Advisory

Healthcare Consultants, Industry Associations, Analysts.

Supply Chain

Distribution and Supply Chain Managers.

Consumers & Advocacy

Patients, Advocacy Groups, Insurance Companies.

Academic & Research

Academic Institutions.

Save 20% on all licenses
Single User$4350$3480Multi User$4850$3880Corporate$7850$6280

Trusted by Global Leaders

ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
FAQ’s

  • AI-Enhanced Electronic Health Records Market is valued at US$ 8.29 billion in 2025 and is projected to reach US$ 84.95 billion by 2035, growing at a CAGR of 26.2% during 2026–2035.

  • Key players are eClinicalWorks, ScienceSoft USA Corporation, Oracle, Medical Information Technology, Inc., athenahealth, and Eleos Health, Inc.

  • The market is driven by increasing adoption of digital healthcare, growing demand for clinical workflow automation, rising healthcare data volumes, physician burnout from administrative tasks, advancements in generative AI and machine learning, regulatory support for healthcare digitization, and the need for improved patient outcomes.

  • AI-enhanced electronic health records are traditional EHR systems integrated with artificial intelligence capabilities such as natural language processing (NLP), machine learning, predictive analytics, and generative AI. These technologies automate documentation, analyze patient data, provide clinical recommendations, and improve healthcare decision-making.

  • Major applications include clinical decision support, medical documentation automation, predictive analytics, population health management, patient risk stratification, medical coding, appointment scheduling, revenue cycle management, medication management, and personalized treatment planning.

  • AI-enhanced EHR systems are used by hospitals, clinics, physician practices, academic medical centers, ambulatory care centers, specialty hospitals, diagnostic laboratories, telehealth providers, healthcare networks, and accountable care organizations (ACOs).

  • AI-enhanced EHRs improve clinical efficiency, reduce documentation time, minimize medical errors, support earlier diagnosis, optimize treatment decisions, enhance patient engagement, improve interoperability, reduce administrative workload, and increase overall healthcare productivity.

  • Key technologies include machine learning (ML), natural language processing (NLP), generative AI, predictive analytics, cloud computing, speech recognition, clinical decision support systems (CDSS), robotic process automation (RPA), interoperability standards, and healthcare analytics platforms.

  • North America currently dominates the market due to widespread EHR adoption, advanced healthcare IT infrastructure, supportive government initiatives, and strong investments in AI-driven healthcare solutions. Europe is another significant market, while Asia-Pacific is expected to witness the fastest growth due to expanding healthcare digitalization, increasing healthcare spending, and rising adoption of cloud-based health information systems.

  • Major challenges include data privacy and security concerns, interoperability issues, integration with legacy systems, high implementation costs, regulatory compliance, algorithm bias, clinician trust in AI recommendations, and the need for high-quality healthcare data.

  • Emerging opportunities include AI-powered clinical copilots, ambient clinical documentation, predictive population health analytics, precision medicine integration, voice-enabled EHR systems, automated coding and billing, digital health assistants, AI-driven care coordination, and interoperability through cloud-based healthcare platforms.

  • The market is expected to witness strong growth as healthcare providers increasingly adopt AI-powered automation to improve efficiency, reduce clinician burnout, enhance interoperability, and support value-based care. Continued advancements in generative AI, predictive analytics, and healthcare cloud technologies are expected to drive widespread adoption.

  • The AI-Enhanced Electronic Health Records Market is important because it transforms patient records into intelligent clinical decision-support systems. By automating documentation, improving diagnostic accuracy, enabling personalized care, reducing administrative burden, and enhancing healthcare workflows, AI-enhanced EHRs play a critical role in improving healthcare quality, operational efficiency, and patient outcomes.
What Our Clients Say About this Report
Wayne M. Brogan
Group Chief Executive Officer, Australia
14 Oct, 2025
5/5
Among the healthcare AI reports we evaluated this year, the AI-Enhanced Electronic Health Records Market study stands out for its clarity, analytical depth, and practical business relevance. DataM Intelligence has delivered comprehensive market intelligence that supports informed executive decision-making through detailed competitive analysis, technology insights, healthcare trends, and regional market assessments.
Sheila J. Patterson
Vice President, Clinical Innovation, USA
09 Dec, 2025
5/5
What impressed us most was the report's ability to connect advances in artificial intelligence with measurable improvements in healthcare delivery. The research clearly demonstrates how AI-enhanced electronic health records are improving clinician productivity, patient outcomes, and data-driven decision-making. It has become an important strategic resource within our organization.
Chiquita R. Pederson
Managing Director, France
04 Feb, 2026
5/5
DataM Intelligence has produced a report that successfully combines healthcare expertise with commercial relevance. The research on AI-powered electronic health records, intelligent automation, and evolving digital healthcare trends supported several important investment decisions across our organization. It is one of the strongest reports available in this field.
Drew M. Anglin
Director, Denmar
08 Apr, 2026
The AI-Enhanced Electronic Health Records Market report gave our leadership team a deeper understanding of competitive dynamics and future business opportunities. The segmentation by EHR type, technology, application, and end user enabled us to identify priority growth areas while strengthening our long-term strategic roadmap. The report is exceptionally well researched.
PDF
DataM
AI-Enhanced Electronic Health Records (EHRs) Market Report
SKU: HCIT8598

Data-Backed Decisions Start Here

Explore how our research empowers industry leaders to cut through uncertainty. Get a free sample of this report or tailor it precisely to your business needs.

ISO 27001 Certified
ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
Related Reports